共 72 条
[1]
Kitagawa Y(2019)Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society: part 1 Esophagus 16 1-24
[2]
Uno T(2019)Esophageal and esophagogastric junction cancers, version 2.2019, NCCN clinical practice guidelines in oncology J Natl Compr Canc Netw 17 855-883
[3]
Oyama T(2009)A phase II trial of chemoradiotherapy for stage I esophageal squamous cell carcinoma: Japan Clinical Oncology Group Study (JCOG9708) Jpn J Clin Oncol 39 638-643
[4]
Ajani JA(2019)Parallel-group controlled trial of esophagectomy versus chemoradiotherapy in patients with clinical stage I esophageal carcinoma (JCOG 0502) J Clin Oncol 37 1106-1111
[5]
D'Amico TA(2006)Treatment results of chemoradiotherapy for clinical stage I (T1N0M0) esophageal carcinoma Int J Radiat Oncol 64 1106-1111
[6]
Bentrem DJ(2011)Patterns of failure associated with involved field radiotherapy in patients with clinical stage I thoracic esophageal cancer Jpn J Clin Oncol 41 1007-1012
[7]
Kato H(2015)Endoscopic submucosal dissection (ESD) with additional therapy for superficial esophageal cancer with submucosal invasion Intern Med 54 2803-2813
[8]
Sato A(2015)Long-term results of definitive concurrent chemoradiotherapy for patients with esophageal submucosal cancer (T1bN0M0) Int J Clin Oncol 20 897-904
[9]
Fukuda H(2020)Comparison of involved field radiotherapy and elective nodal irradiation in combination with concurrent chemotherapy for T1bN0M0 esophageal cancer Int J Clin Oncol 25 1098-1104
[10]
Kato K(2011)Comparison between definitive chemoradiotherapy and esophagectomy in patients with clinical stage I esophageal squamous cell carcinoma Am J Gastroenterol 106 1048-1054